Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on CAS 176010 20 1. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN102206164A details a cleaner route for Tapentadol intermediates using PCl5 and catalytic hydrogenation, offering significant cost and safety advantages for API manufacturing.